The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pamidronate|DRUG: Zoledronic acid|DRUG: placebo
Sponsor: Ottawa Hospital Research Institute
Collaborators: Canadian Breast Cancer Foundation